Bact GI 3 Flashcards
Describe The characteristics of the Vibrio spp.
- Gram-negative, Facultative anaerobes
- CURVED SHAPED (comma’s)
- Free-living in water
- Broad temp. range of growth
- Broad pH range of growth
- REQUIRE SODIUM CHLORIDE for growth
- *SMALL INTESTINE DISEASE**
Describe the clinical manifestations of Vibrio Cholerae
Causes Cholera:
- Ranges from Asymptomatic to SEVERE watery Diarrhea
- 2 to 3 day incubation
- lasts up to 7 days
- *5-25% develop SEVERE Watery diarrhea**
- ABRUPT onset
- 150lb person loses 4.5 gallons a day
- RICE WATER STOOL
- CAN kill within hours via dehydration
Describe the Pathogenesis of Vibrio Cholerae
1) TOXIN co-regulated pilus (TCP) mediates adherence to intestinal epithelial cells
2) Cholera toxin is produced
- AB toxin that activates adenylate cyclase which increase cAMP which causes massive efflux of watery secretions
- NO CELL DAMAGE
- SIMILAR to ETEC LT toxin
Describe the diagnosis and treatment of Vibrio cholerae
DIAGNOSIS: culture on differential media
TREATMENT: rehydration therapy via IV and oral
- without rehydration, mortality can be as high as 90%
Describe Vibrio parahaemolyticus
INFLAMMATORY SMALL INTESTINE DISEASE
- Explosive watery diarrhea, nausea, vomiting, abdominal cramps, low grade fever
VIRULENCE = Kanagawa hemolysin - induces chloride secretion thus watery diarrhea
EPIDEMIOLOGY = associated with consumption of raw shellfish
TREATMENT/PREVENTION = Self-limiting and proper cooking of shellfish
Describe Yersinia enterocolitica
- Gram negative coccobacilli
INFLAMMATORY SMALL INTESTINE - Due to heat-stable ENTEROTOXIN
- Fever, abdominal cramps, watery or bloody diarrhea
- lasts 1-2 weeks
DIAGNOSIS = Culture of stool
TREATMENT = self-limiting
Describe the characteristics of Clostridium difficile
- Gram Positive anaerobe
- NON-invasive
- SPORE FORMING
- *INFLAMMATORY LARGE INTESTINE DISEASE**
- disease and symptoms vary
Describe the clinical manifestations of Clostridium difficile: C. Difficile-associated diarrhea (CHAD)
DIARRHEA = watery diarrhea, feval leukocytes, occult blood sometimes seen
- Nausea, anorexia, fever, malaise, dehydration, leukocytosis with left shift
- Abdominal distention and tenderness
- Diffuse or patchy nonspecific colitis in sigmoidoscopic exam
Describe the clinical manifestations of Clostridium difficile: Pseudomembrane colitis
DIARRHEA = profuse watery diarrhea, fecal leukocytes, occult blood sometimes seen
- More severe symptoms than CHAD (same)
- Marked abdominal distention, tenderness
- Sigmoidoscopic exam reveals raised, adherent yellow plaques
Describe the clinical manifestations of Clostridium difficile: Fulminant colitis
DIARRHEA = severe or diminished
- lethargy, fever, tachycardia, may observe dilated colon on abdominal film
- May present as sudden, severe abdominal pain
- sigmoidoscopic exam is contraindicated
- surgical consult required.
Describe the pathogenesis of Clostridium difficile
- Toxin A and Toxin B cause damage to mucosa –> disrupts host cell cytoskeleton = diarrhea
Describe the diagnosis and treatment of clostridium difficile
DIAGNOSIS: toxin detection in stool (culture NOT helpful)
TREATMENT = oral VANCOMYCIN or METRONIDAZOLE
PREVENTION = fecal transplant
Describe the characteristics of Intestine Enterohemorrhagic E. Coli (EHEC)
- Gram Negative, Facultate anaerobe
- O157:H7 (binding site)
- Animal reservoirs = cattle or other ruminants
- Generally NON-invasive
- *INFLAMMATORY LARGE INTESTINE DISEASE)
- associated with contaminated ground beef and vegitables
Describe the Clinical Manifestations of EHEC
- Hemorrhagic colitis = bloody diarrhea
- NO FEVER, marked abdominal tenderness
- Sequelae - hemolytic uremic syndrome (HUS) = anemia and kidney failure
Describe the pathogenesis of EHEC
1) E. Coli O157:H7 binds to brush border of intestinal mucosa
2) E. Coli O157:H7 produces verotoxin that destroy microvilli
3) Verotoxin enters blooding causing vascular endothelial damage and increasing platelet aggregation
4) platelet-fibrin thrombi form causing ischemic damage to colon, kidney and other tissues (Hemorrhagic colitis and Hemolytic Uremic syndrome)